Brought to you by 
Acorn Cardiovascular gets $16.3mm in Series C financing
29 May 2012
Executive Summary
Acorn Cardiovascular, a company which designs medical devices to treat congestive heart failure (CHF), has completed a private placement of Series C preferred shares, raising a total of $16.3mm.
Deal Industry
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Acorn Cardiovascular gets $16.3mm in Series C financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice